Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers.

Koch K, Kalusche S, Torres JL, Stanfield RL, Danquah W, Khazanehdari K, von Briesen H, Geertsma ER, Wilson IA, Wernery U, Koch-Nolte F, Ward AB, Dietrich U.

Sci Rep. 2017 Aug 21;7(1):8390. doi: 10.1038/s41598-017-08273-7.

2.

Geographic Distribution and Temporal Trends of HIV-1 Subtypes through Heterosexual Transmission in China: A Systematic Review and Meta-Analysis.

Xiao P, Li J, Fu G, Zhou Y, Huan X, Yang H.

Int J Environ Res Public Health. 2017 Jul 24;14(7). pii: E830. doi: 10.3390/ijerph14070830. Review.

3.

Hazardous alcohol consumption is not associated with CD4+ T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study.

Wandera B, Tumwesigye NM, Nankabirwa JI, Kambugu AD, Mafigiri DK, Kapiga S, Sethi AK.

PLoS One. 2017 Jun 30;12(6):e0180015. doi: 10.1371/journal.pone.0180015. eCollection 2017.

4.

Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions.

Reis MNDG, Bello G, Guimarães ML, Stefani MMA.

PLoS One. 2017 Jun 19;12(6):e0178578. doi: 10.1371/journal.pone.0178578. eCollection 2017.

5.

Rising prevalence of non-B HIV-1 subtypes in North Carolina and evidence for local onward transmission.

Dennis AM, Hué S, Learner E, Sebastian J, Miller WC, Eron JJ.

Virus Evol. 2017 May 24;3(1):vex013. doi: 10.1093/ve/vex013. eCollection 2017 Jan.

6.

HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naïve individuals in Surabaya, Indonesia.

Kotaki T, Khairunisa SQ, Witaningrum AM, M MQY, Sukartiningrum SD, Diansyah MN, Rahayu RP, Nasronudin ᅟ, Kameoka M.

AIDS Res Ther. 2015 Feb 22;12:5. doi: 10.1186/s12981-015-0046-y. eCollection 2015.

7.

Recent advances in understanding HIV evolution.

Andrews SM, Rowland-Jones S.

F1000Res. 2017 Apr 28;6:597. doi: 10.12688/f1000research.10876.1. eCollection 2017. Review.

8.

A national study of the molecular epidemiology of HIV-1 in Australia 2005-2012.

Castley A, Sawleshwarkar S, Varma R, Herring B, Thapa K, Dwyer D, Chibo D, Nguyen N, Hawke K, Ratcliff R, Garsia R, Kelleher A, Nolan D; Australian Molecular Epidemiology Network-HIV (AMEN-HIV).

PLoS One. 2017 May 10;12(5):e0170601. doi: 10.1371/journal.pone.0170601. eCollection 2017.

9.

Molecular and epidemiological characterization of HIV-1 subtypes among Libyan patients.

Daw MA, El-Bouzedi A, Ahmed MO, Dau AA; In association with the Libyan Study Group of Hepatitis & HIV.

BMC Res Notes. 2017 Apr 28;10(1):170. doi: 10.1186/s13104-017-2491-2.

10.

Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.

Kiguoya MW, Mann JK, Chopera D, Gounder K, Lee GQ, Hunt PW, Martin JN, Ball TB, Kimani J, Brumme ZL, Brockman MA, Ndung'u T.

J Virol. 2017 Jun 9;91(13). pii: e00253-17. doi: 10.1128/JVI.00253-17. Print 2017 Jul 1.

PMID:
28424286
11.

Genetic characterization and antiretroviral resistance mutations among treatment-naive HIV-infected individuals in Jiaxing, China.

Guo J, Yan Y, Zhang J, Ji J, Ge Z, Ge R, Zhang X, Wang H, Chen Z, Luo J.

Oncotarget. 2017 Mar 14;8(11):18271-18279. doi: 10.18632/oncotarget.15382.

12.

Contrasting antibody responses to intrasubtype superinfection with CRF02_AG.

Courtney CR, Mayr L, Nanfack AJ, Banin AN, Tuen M, Pan R, Jiang X, Kong XP, Kirkpatrick AR, Bruno D, Martens CA, Sykora L, Porcella SF, Redd AD, Quinn TC, Nyambi PN, Dürr R.

PLoS One. 2017 Mar 13;12(3):e0173705. doi: 10.1371/journal.pone.0173705. eCollection 2017.

13.

Insights into the activity of maturation inhibitor PF-46396 on HIV-1 clade C.

Ghimire D, Timilsina U, Srivastava TP, Gaur R.

Sci Rep. 2017 Mar 2;7:43711. doi: 10.1038/srep43711.

14.

Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies.

Chaillon A, Essat A, Frange P, Smith DM, Delaugerre C, Barin F, Ghosn J, Pialoux G, Robineau O, Rouzioux C, Goujard C, Meyer L, Chaix ML; on behalf the ANRS PRIMO Cohort Study.

Retrovirology. 2017 Feb 21;14(1):15. doi: 10.1186/s12977-017-0339-4.

15.

Unusual Fusion Proteins of HIV-1.

Langer S, Sauter D.

Front Microbiol. 2017 Jan 9;7:2152. doi: 10.3389/fmicb.2016.02152. eCollection 2016. Review.

16.

The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa.

Sharma S, Aralaguppe SG, Abrahams MR, Williamson C, Gray C, Balakrishnan P, Saravanan S, Murugavel KG, Solomon S, Ranga U.

BMC Infect Dis. 2017 Jan 24;17(1):95. doi: 10.1186/s12879-017-2184-4.

17.

Evaluation of novel protease inhibitors against darunavir-resistant variants of HIV type 1.

Inoue M, Oyama D, Hidaka K, Kameoka M.

FEBS Open Bio. 2016 Nov 24;7(1):88-95. doi: 10.1002/2211-5463.12160. eCollection 2017 Jan.

18.

Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon.

De Oliveira F, Mourez T, Vessiere A, Ngoupo PA, Alessandri-Gradt E, Simon F, Rousset D, Plantier JC.

Retrovirology. 2017 Jan 13;14(1):1. doi: 10.1186/s12977-016-0324-3.

19.

Sensitive Next-Generation Sequencing Method Reveals Deep Genetic Diversity of HIV-1 in the Democratic Republic of the Congo.

Rodgers MA, Wilkinson E, Vallari A, McArthur C, Sthreshley L, Brennan CA, Cloherty G, de Oliveira T.

J Virol. 2017 Feb 28;91(6). pii: e01841-16. doi: 10.1128/JVI.01841-16. Print 2017 Mar 15.

20.

DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.

Chege GK, Burgers WA, Müller TL, Gray CM, Shephard EG, Barnett SW, Ferrari G, Montefiori D, Williamson C, Williamson AL.

Vaccine. 2017 Feb 7;35(6):929-937. doi: 10.1016/j.vaccine.2016.12.060. Epub 2017 Jan 6.

Supplemental Content

Support Center